Ultralife Q3 2026 earnings

ULBI · 2026-11-09 15:37 during market hours ET · 8-K on SEC

Revenue grew 11.3% YoY, but gross margin declined 1.4 pp YoY due to a shift in product mix and lower warranty costs in Communications Systems.

Headline numbers

MetricActualYoYQoQ8-K location
Revenue$48.3M+11.3%+0.5%Ex. 99.1, income statement
EPS (GAAP)$0.14+0.21-0.01Ex. 99.1, income statement
EPS (adjusted)$0.14+0.21-0.01Ex. 99.1, income statement
Net income$2.4M+$3.6M-$0.1MEx. 99.1, income statement
Adj. EBITDA$5.6M+$3.6M-$0.5MEx. 99.1, income statement
Adj. EBITDA margin11.7%+7.0 pp-1.1 ppEx. 99.1, income statement

Revenue breakdown

SegmentActualYoYShare of revenueNote
Battery & Energy Products$45.1M+12.9%93.4%Government/defense sales grew 56.7%
Communications Systems$3.2M-7.1%6.6%Lower warranty costs and sales mix

Margins and costs

  • Gross margin 27.5% (22.2% prior, -1.4 pp YoY)
  • Operating expenses $10.1M (+4.4% YoY)
  • One-offs in the quarter One-time, non-recurring costs of $0.6M related to the closing of the Calgary facility and consulting costs; One-Time Events Impacting Production of $0.3M; Severance and Other Costs for Plant Closure of $0.5M; Non-Cash Purchase Accounting Adjustment of $0.4M
  • Effective tax rate 15.3% (prior-year -28.7%, year-to-date 14.1%)
  • Non-GAAP bridge Adds back Interest Expense, Net; Income Tax Provision; Depreciation Expense; Amortization Expense; Stock-Based Compensation Expense; Other Non-Recurring Costs; One-Time Events Impacting Production; Severance and Other Costs for Plant Closure; Non-Cash Purchase Accounting Adjustment.

KPIs

MetricActualPrior quarterPrior yearChange
Backlog$136.0M$117.5M$90.3M+15.7% QoQ, +50.6% YoY
Cash$8.6M$6.7M$8.7M+28.4% QoQ, -1.2% YoY
Inventories$62.3M$58.7M$54.0M+6.1% QoQ, +15.3% YoY

Guidance

not stated in the 8-K

What drove it

  • Revenue story Battery & Energy Products revenue grew 12.9% YoY, driven by a 56.7% increase in government/defense sales due to a large order for conformal wearable batteries, offset by a 5.8% decrease in commercial sales due to softness in the global oil & gas market. Communications Systems revenue decreased 7.1% YoY.
  • EPS story EPS moved from a loss of ($0.07) in Q3 2025 to a profit of $0.14 in Q3 2026, driven by improved operating income and a lower tax rate.
  • One-off check One-time, non-recurring costs of $0.6M related to the closing of the Calgary facility and consulting costs.

The good

  • Revenue grew 11.3% YoY
  • Adjusted EBITDA margin improved 7.0 pp YoY to 11.7%
  • Backlog reached a record $136.0M

The bad

  • Communications Systems revenue declined 7.1% YoY
  • Gross margin declined 1.4 pp YoY
  • Operating expenses increased 4.4% YoY

The ugly

  • none

Open questions

  • The filing does not disclose the specific value of the large order for conformal wearable batteries.
  • The filing does not disclose the specific value of the large order for an allied country mentioned in the prior release.
Full release

Ultralife (ULBI) earnings release, November 9, 2026

Ultralife Corp (ULBI) · Form 8-K, Item 2.02 · Filed · SEC filing

Ultralife Corporation Reports Third Quarter Results

NEWARK, N.Y. – November 5, 2026 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2026 with the following results:

On October 27, 2026, Ultralife announced that it has agreed to be acquired by EnerSys (NYSE: ENS) in an all-cash transaction valued at approximately $320 million, including the assumption of net debt. The transaction is expected to close in the first quarter of 2027. In light of this pending transaction, Ultralife will not hold a conference call to discuss third quarter results.

Third Quarter 2026 Financial Results

Revenue was $48.3 million, an increase of $4.9 million, or 11.3%, as compared to revenue of $43.4 million for the third quarter of 2025. Battery & Energy Products sales increased 12.9% to $45.1 million compared to $39.9 million last year. The year-over-year increase reflects 56.7% growth in government/defense sales due primarily to a large order for conformal wearable batteries, partially offset by 5.8% decrease in commercial sales primarily due to softness in the global oil & gas market. Communications Systems sales decreased by 7.1% to $3.2 million compared to $3.4 million for the same period last year. Our total backlog exiting the third quarter was $136.0 million, the highest level in the Company’s history, compared to $117.5 million exiting the second quarter of 2026 and $90.3 million exiting the third quarter of 2025.

Gross profit was $13.3 million, or 27.5% of revenue, compared to $9.6 million, or 22.2% of revenue, for the same quarter a year ago. Battery & Energy Products gross margin was 26.7%, compared to 22.1% last year, primarily due to progress in improving manufacturing efficiencies and vertical integration of our thionyl-chloride cells as well as favorable product mix. Communications Systems gross margin was 40.1% compared to 23.3% last year, primarily due to lower warranty costs and sales mix.

Operating expenses were $10.1 million, compared to $10.6 million for the third quarter of 2025, reflecting an increase in new product development costs related to continued investment in our product offering, and a decrease in one-time, non-recurring costs of $0.6 million primarily related to the closing of our Calgary facility and certain consulting costs to help expedite our gross margin improvement in the year-earlier period. Operating expenses were 20.9% of revenue compared to 24.4% of revenue for the year-earlier period.

Operating income was $3.2 million compared to an operating loss of $1.0 million last year.

Other expense was $0.4 million primarily comprised of interest expense from the financing of our Electrochem acquisition partially offset by the third quarter estimated portion of a refundable tax credit for certain qualifying battery cells and packs we manufacture under the 45X Advanced Manufacturing Production Tax Credit. This compares to $0.8 million for the year-earlier period primarily reflecting the Electrochem acquisition financing and net foreign currency gains.

Net income attributable to Ultralife Corporation was $2.4 million or $0.14 per basic and diluted share on a GAAP basis, compared to a net loss of ($1.2) million or ($0.07) per basic and diluted share for the third quarter of 2025.

Adjusted EBITDA, defined as EBITDA including non-cash, stock-based compensation expense and one-time costs not reflective of our ongoing operations, was $5.6 million for the third quarter of 2026, or 11.7% of sales, compared to $2.0 million, or 4.7% of sales, for the year-earlier period. On a trailing twelve-month basis, adjusted EBITDA was $20.7 million or 10.8% of sales.

See the “Non-GAAP Financial Measures” section of this release below for a reconciliation of adjusted EBITDA to net income attributable to Ultralife Corporation.

About Ultralife Corporation

Ultralife Corporation is a global leader in mission-critical battery, power, communications and compute solutions for the most demanding applications in government/defense, medical, oil & gas and industrial markets across the globe.

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

Financial statements

Income Statement

Three-Month Period Ended — (Unaudited) (in thousands)

Three-Month Period Ended – September2026Three-Month Period Ended – September2025Nine-Month Period Ended – September2026Nine-Month Period Ended – September2025
30303030
Revenues:
Battery & Energy Products45,08939,946133,433132,134
Communications Systems3,1823,42510,22610,544
Total Revenues48,27143,371143,659142,678
Cost of Products Sold:
Battery & Energy Products33,07131,12699,554101,039
Communications Systems1,9072,6266,8367,674
Total Cost of Products Sold34,97833,752106,390108,713
Gross Profit13,2939,61937,26933,965
Operating Expenses:
Research and Development3,1892,8559,3757,577
Selling, General and Administrative6,9187,71521,48621,684
Total Operating Expenses10,10710,57030,86129,261
Operating Income (Loss)3,186-9516,4084,704
Other Expense4418001,3402,896
Income (Loss) Before Income Taxes2,745-1,7515,0681,808
Income Tax Provision (Benefit)362-504638306
Net Income (Loss)2,383-1,2474,4301,502
Net Income (Loss) Attributable to Non-Controlling Interest15-27-30-22
Net Income (Loss) Attributable to Ultralife Corporation2,368-1,2204,4601,524
Net Income (Loss) Per Share Attributable to Ultralife Common Shareholders – Basic0.14-0.070.270.09
Net Income (Loss) Per Share Attributable to Ultralife Common Shareholders – Diluted0.14-0.070.270.09
Weighted Average Shares Outstanding – Basic16,66416,64616,66016,638
Weighted Average Shares Outstanding – Diluted16,69716,64616,70316,699

Income Statement

Three-Month Period Ended — (Unaudited) (in thousands)

Three-Month Period Ended – September 30, 2026Three-Month Period Ended – September 30, 2025Nine-Month Period Ended – September 30, 2026Nine-Month Period Ended – September 30, 2025
Net Income (Loss) Attributable to Ultralife Corporation2,368-1,2204,4601,524
Adjustments:
Interest Expense, Net9219922,6283,016
Income Tax Provision (Benefit)362-504638306
Depreciation Expense1,0981,0083,2082,966
Amortization Expense2674118021,226
Stock-Based Compensation Expense92236181698
Other Non-Recurring Costs2785942,0091,112
One-Time Events Impacting Production2501,067
Severance and Other Costs for Plant Closure491641
Non-Cash Purchase Accounting Adjustment40120
Adjusted EBITDA5,6362,04814,99311,609

Balance Sheet

September 30, — (Unaudited) (in thousands)

September 30, – 2026 – ASSETSDecember 31, – 2025 – ASSETS
Current Assets:
Cash8,6289,345
Trade Accounts Receivable, Net35,79033,948
Inventories, Net62,31454,008
Prepaid Expenses and Other Current Assets9,9148,500
Total Current Assets116,646105,801
Property, Plant and Equipment, Net39,01140,397
Goodwill45,40345,376
Other Intangible Assets, Net10,12110,933
Deferred Income Taxes, Net10,02910,494
Other Non-Current Assets3,1933,911
Total Assets224,403216,912
Current Liabilities:
Accounts Payable19,58117,423
Current Portion of Long-Term Debt3,1254,125
Accrued Compensation and Related Benefits2,9412,754
Accrued Expenses and Other Current Liabilities13,67313,031
Total Current Liabilities39,32037,333
Long-Term Debt, Net47,39345,526
Deferred Income Taxes, Net8971,000
Other Non-Current Liabilities2,1562,919
Total Liabilities89,76686,778
Shareholders' Equity:
Common Stock2,1102,109
Capital in Excess of Par Value193,081192,859
Accumulated Deficit-35,880-40,340
Accumulated Other Comprehensive Loss-3,291-3,141
Treasury Stock-21,492-21,492
Total Ultralife Equity134,528129,995
Non-Controlling Interest109139
Total Shareholders’ Equity134,637130,134
Total Liabilities and Shareholders' Equity224,403216,912

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include uncertain global economic conditions including the impact of tariffs and inflation, reductions in revenues from key customers, delays or reductions in U.S. and foreign military spending, acceptance of our new products on a global basis, and disruptions, delays or material price increases in our supply of raw materials and components due to business conditions, new or additional tariffs, global conflicts, weather or other factors not under our control. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Ultralife earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.